Before the opening bell, Laguna Blends, Inc. (CSE: LAG) (OTC: LAGBF) (Frankfurt: LB6A.F) announced its inclusion on the Canadian Securities Exchange (CSE) Composite index. Criteria for inclusion on the CSE Composite index include active listing on the CSE, a market capitalization of at least $5 million and a seasoning requirement. At each quarterly rebalance, companies included in the index are assessed to ensure a minimum market capitalization of at least $4 million, with companies that fail to meet this criteria being subject to index deletion. The market cap of Laguna Blends was listed at $6.34 million as of September 19, 2016.
“Inclusion in the CSE Composite index is another indicator Laguna continues to deliver shareholder value through its strategic growth strategy,” Bryan Loree, chief financial officer of Laguna, stated in this morning’s news release. “Laguna has positioned itself to be a dominant player in the distribution and marketing of unique hemp and CBD related products around the world.”
Laguna Blends leverages a growing network of independent affiliates to generate retail sales of multiple products in the United States and Canada. The company’s initial products to market are Caffe, an instant hot coffee beverage infused with whey and hemp protein, and Pro369, a single serving hemp protein powder available in four delicious flavors. In June, Laguna highlighted the marketability of these offerings when it announced the generation of $105,000 in unaudited sales in the first 11 weeks following commencement of operations. With the geometric growth opportunities presented by the company’s network marketing strategy, this strong start put Laguna “on track with its long term sales growth strategy,” according to President Ray Grimm Jr.
In recent weeks, Laguna has turned much of its attention toward its entry into the $121 billion global skin care market. The company entered into an exclusive agreement to distribute Swiss-made Cannaceuticals (“Canna”) cannabidiol (CBD) skin care products in the United States and, upon regulatory approval, Canada, Asia, Europe and Mexico. In a recent clinical study evaluating the efficacy of these products, Canna’s CBD facial serum produced an overall improvement to the appearance of skin in 100 percent of test subjects in just two weeks. On September 13, Laguna announced the VIP launch of the Canna CBD skin care products to its existing affiliates in the U.S., marking a significant step in its efforts to become a major player within the skin care industry.
For more information, visit www.lagunablends.com
Let us hear your thoughts: Laguna Blends, Inc. Message Board
